Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
6.21
+1.87 (43.09%)
At close: Aug 6, 2026, 4:00 PM EDT
6.25
+0.04 (0.64%)
Pre-market: Aug 7, 2026, 6:07 AM EDT
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 975 employees as of December 31, 2025. The number of employees increased by 137 or 16.35% compared to the previous year.
Employees
975
Change (1Y)
137
Growth (1Y)
16.35%
Revenue / Employee
$333,302
Profits / Employee
-$296,941
Market Cap
2.77B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 975 | 137 | 16.35% |
| Dec 31, 2024 | 838 | 281 | 50.45% |
| Dec 31, 2023 | 557 | 54 | 10.74% |
| Dec 31, 2022 | 503 | 184 | 57.68% |
| Dec 31, 2021 | 319 | 78 | 32.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Agios Pharmaceuticals | 540 |
| Ocular Therapeutix | 325 |
| Zenas BioPharma | 167 |
| Aurinia Pharmaceuticals | 128 |
| Nanobiotix | 100 |
| Rapport Therapeutics | 84 |
| Mesoblast | 81 |
| GH Research | 73 |
IOVA News
- 6 minutes ago - Iovance Biotherapeutics price target raised to $8 from $5 at Citizens - TheFly
- 47 minutes ago - Iovance Biotherapeutics price target raised to $13 from $11 at Barclays - TheFly
- 21 hours ago - Iovance Biotherapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 21 hours ago - Iovance Biotherapeutics Earnings release: Q2 2026 - Filings
- 21 hours ago - Iovance Biotherapeutics Quarterly report: Q2 2026 - Filings
- 22 hours ago - Iovance Biotherapeutics backs FY26 revenue view $350M-370M, consensus $352M - TheFly
- 22 hours ago - Iovance Biotherapeutics reports Q2 EPS (11c), consensus (13c) - TheFly
- 23 hours ago - Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates - GlobeNewsWire